⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EBS News
Emergent Biosolutions, Inc.
Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026
globenewswire.com
EBS
Form 8-K
sec.gov
EBS
Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
globenewswire.com
EBS
2026 John Cotton Dana Awards Celebrate 80 Years of Recognizing Excellence in Library Marketing and Communications
prnewswire.com
EBS
Biodefense Market Size to Reach USD 29.17 Billion by 2035 | SNS Insider
globenewswire.com
EBS
SIGA
NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
accessnewswire.com
NNVC
GILD
SIGA
EBS
EBSCO Clinical Decisions and AWHONN Partner to Drive Clinical Excellence in Women's Health, Obstetric and Neonatal Nursing
prnewswire.com
EBS
Nearly 800 Gather for the 23rd Annual Latinas in Leadership Symposium; Civil Rights Icon Dolores Huerta Defines Leadership as "People Who Do the Work"
prnewswire.com
TJX
EBS
WBS
MASS
Victoria's Voice Foundation Marks National Naloxone Awareness Day on June 6
prnewswire.com
EBS
Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose
globenewswire.com
EBS